SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lincoln Pharmaceuticals informs about issuance of duplicate share certificate

12 May 2023 Evaluate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that the Company has received the enclosed intimation letter from its RTA –Link Intime India, regarding the duplicate share certificate of the Company that have been issued, the details of which are enclosed. Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder/claimant upon completion of necessary procedures regarding duplicate share certificates.

The above information is a part of company’s filings submitted to BSE.


Lincoln Pharma Share Price

645.00 -0.40 (-0.06%)
04-May-2026 10:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.40
Dr. Reddys Lab 1304.40
Cipla 1324.55
Zydus Lifesciences 897.40
Lupin 2335.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×